In vitro pharmacological inhibition of Eg5 decreases endothelial cell proliferation and migration, while in in vivo zebrafish and chick embryos models, interference with Eg5 function causes developmental and vascular defects, along to inhibition of angiogenesis in tumor models [13]. Here, KIF11 is linked to neoplasm.